Skip to main content

Advertisement

SpringerLink
Log in

Management of resectable colorectal lung metastases

  • Review
  • Published:
Clinical & Experimental Metastasis Aims and scope Submit manuscript

Abstract

Lung metastases occur in 10–20 % of patients with colorectal cancer. The biology of colorectal lung metastases is poorly understood, however lung metastases are more common in patients with rectal cancer and in patients with RAS mutations. Although the majority of patients have extrapulmonary disease, a small proportion of patients with lung metastases are suitable for lung metastasectomy and surgical resection has become a standard of care, based on data from retrospective series demonstrating a 5-year overall survival of 40–68 %. However, there remains uncertainty regarding the optimal management approach for these patients due to the lack of evidence from randomized controlled trials and current practice varies between institutions. For example, the role for neoadjuvant and adjuvant chemotherapy is not yet defined and there are no randomized trials comparing surgery with alternative treatment options such as radiofrequency ablation and stereotactic ablative radiotherapy. Further research is needed to improve the selection of patients for surgery, but favourable prognostic factors include a normal pre-operative CEA, solitary metastasis, complete resection and a long disease-free interval. There is also evidence that patients with resectable liver and lung metastases may benefit from resection of both sites of disease, and that re-resection may be of benefit in selected patients who relapse with resectable lung metastases. This article summarizes the biology of colorectal lung metastases and discusses the management of patients with lung metastases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Tan KK, Lopes Gde Jr. L, Sim R (2009) How uncommon are isolated lung metastases in colorectal cancer? A review from database of 754 patients over 4 years. J Gastrointest Surg 13(4):642–648. doi:10.1007/s11605-008-0757-7

    Article  PubMed  Google Scholar 

  2. Penna C, Nordlinger B (2002) Colorectal metastasis (liver and lung). The Surgical clinics of North America 82(5):1075–1090, x–xi

  3. Mitry E, Guiu B, Cosconea S, Jooste V, Faivre J, Bouvier AM (2010) Epidemiology, management and prognosis of colorectal cancer with lung metastases: a 30-year population-based study. Gut 59(10):1383–1388. doi:10.1136/gut.2010.211557

    Article  PubMed  Google Scholar 

  4. Cancer Research UK (2014) Bowel cancer Key Stats. http://www.cancerresearchuk.org/cancer-info/cancerstats/keyfacts/bowel-cancer/

  5. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ (2008) Cancer statistics 2008. Cancer J Clin 58(2):71–96. doi:10.3322/CA.2007.0010

    Article  Google Scholar 

  6. Van Cutsem E, Cervantes A, Nordlinger B, Arnold D, Group EGW (2014) Metastatic colorectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 25(Suppl 3):iii1–iii9. doi:10.1093/annonc/mdu260

    Article  PubMed  Google Scholar 

  7. Munoz Llarena A, Carrera Revilla S, Gil-Negrete Laborda A, Pac Ferrer J, Barcelo Galindez R, Lopez Vivanco G (2007) Prognostic factors associated with resectable pulmonary metastases from colorectal cancer. Arch Bronconeumol 43(6):309–316

    Article  PubMed  Google Scholar 

  8. Chiang JM, Hsieh PS, Chen JS, Tang R, You JF, Yeh CY (2014) Rectal cancer level significantly affects rates and patterns of distant metastases among rectal cancer patients post curative-intent surgery without neoadjuvant therapy. World J Surg Oncol 12:197. doi:10.1186/1477-7819-12-197

    Article  PubMed  PubMed Central  Google Scholar 

  9. Zisis C, Tsakiridis K, Kougioumtzi I, Zarogoulidis P, Darwiche K, Machairiotis N, Zaric B, Katsikogiannis N, Kesisis G, Stylianaki A, Li Z, Zarogoulidis K (2013) The management of the advanced colorectal cancer: management of the pulmonary metastases. J Thorac Dis 5(Suppl 4):S383–S388. doi:10.3978/j.issn.2072-1439.2013.06.23

    PubMed  PubMed Central  Google Scholar 

  10. Gupta GP, Minn AJ, Kang Y, Siegel PM, Serganova I, Cordon-Cardo C, Olshen AB, Gerald WL, Massague J (2005) Identifying site-specific metastasis genes and functions. Cold Spring Harb Symp Quant Biol 70:149–158. doi:10.1101/sqb.2005.70.018

    Article  CAS  PubMed  Google Scholar 

  11. Gupta GP, Massague J (2006) Cancer metastasis: building a framework. Cell 127(4):679–695. doi:10.1016/j.cell.2006.11.001

    Article  CAS  PubMed  Google Scholar 

  12. Psaila B, Lyden D (2009) The metastatic niche: adapting the foreign soil. Nat Rev Cancer 9(4):285–293. doi:10.1038/nrc2621

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Keeley EC, Mehrad B, Strieter RM (2010) CXC chemokines in cancer angiogenesis and metastases. Adv Cancer Res 106:91–111. doi:10.1016/S0065-230X(10)06003-3

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Guillemot E, Karimdjee-Soilihi B, Pradelli E, Benchetrit M, Goguet-Surmenian E, Millet MA, Larbret F, Michiels JF, Birnbaum D, Alemanno P, Schmid-Antomarchi H, Schmid-Alliana A (2012) CXCR7 receptors facilitate the progression of colon carcinoma within lung not within liver. Br J Cancer 107(12):1944–1949. doi:10.1038/bjc.2012.503

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Verbeke H, Struyf S, Laureys G, Van Damme J (2011) The expression and role of CXC chemokines in colorectal cancer. Cytokine Growth Factor Rev 22(5–6):345–358. doi:10.1016/j.cytogfr.2011.09.002

    Article  CAS  PubMed  Google Scholar 

  16. Yaeger R, Cercek A, Chou JF, Sylvester BE, Kemeny NE, Hechtman JF, Ladanyi M, Rosen N, Weiser MR, Capanu M, Solit DB, D’Angelica MI, Vakiani E, Saltz LB (2014) BRAF mutation predicts for poor outcomes after metastasectomy in patients with metastatic colorectal cancer. Cancer 120(15):2316–2324. doi:10.1002/cncr.28729

    Article  CAS  PubMed  Google Scholar 

  17. Tol J, Nagtegaal ID, Punt CJ (2009) BRAF mutation in metastatic colorectal cancer. New Engl J Med 361(1):98–99. doi:10.1056/NEJMc0904160

    Article  CAS  PubMed  Google Scholar 

  18. Di Nicolantonio F, Martini M, Molinari F, Sartore-Bianchi A, Arena S, Saletti P, De Dosso S, Mazzucchelli L, Frattini M, Siena S, Bardelli A (2008) Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancer. J Clin Oncol 26(35):5705–5712. doi:10.1200/JCO.2008.18.0786

    Article  PubMed  CAS  Google Scholar 

  19. Ki DH, Jeung HC, Park CH, Kang SH, Lee GY, Lee WS, Kim NK, Chung HC, Rha SY (2007) Whole genome analysis for liver metastasis gene signatures in colorectal cancer. Int J Cancer 121(9):2005–2012. doi:10.1002/ijc.22975

    Article  CAS  PubMed  Google Scholar 

  20. Lin HM, Chatterjee A, Lin YH, Anjomshoaa A, Fukuzawa R, McCall JL, Reeve AE (2007) Genome wide expression profiling identifies genes associated with colorectal liver metastasis. Oncol Rep 17(6):1541–1549

    CAS  PubMed  Google Scholar 

  21. Rao US, Hoerster NS, Thirumala S, Rao PS (2013) The influence of metastatic site on the expression of CEA and cellular localization of beta-catenin in colorectal cancer. J Gastroenterol Hepatol 28(3):505–512. doi:10.1111/jgh.12083

    Article  CAS  PubMed  Google Scholar 

  22. Albanese I, Scibetta AG, Migliavacca M, Russo A, Bazan V, Tomasino RM, Colomba P, Tagliavia M, La Farina M (2004) Heterogeneity within and between primary colorectal carcinomas and matched metastases as revealed by analysis of Ki-ras and p53 mutations. Biochem Biophys Res Commun 325(3):784–791. doi:10.1016/j.bbrc.2004.10.111

    Article  CAS  PubMed  Google Scholar 

  23. Tie J, Lipton L, Desai J, Gibbs P, Jorissen RN, Christie M, Drummond KJ, Thomson BN, Usatoff V, Evans PM, Pick AW, Knight S, Carne PW, Berry R, Polglase A, McMurrick P, Zhao Q, Busam D, Strausberg RL, Domingo E, Tomlinson IP, Midgley R, Kerr D, Sieber OM (2011) KRAS mutation is associated with lung metastasis in patients with curatively resected colorectal cancer. Clin Cancer Res 17(5):1122–1130. doi:10.1158/1078-0432.CCR-10-1720

    Article  CAS  PubMed  Google Scholar 

  24. Kim MJ, Lee HS, Kim JH, Kim YJ, Kwon JH, Lee JO, Bang SM, Park KU, Kim DW, Kang SB, Kim JS, Lee JS, Lee KW (2012) Different metastatic pattern according to the KRAS mutational status and site-specific discordance of KRAS status in patients with colorectal cancer. BMC Cancer 12:347. doi:10.1186/1471-2407-12-347

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Yaeger R, Cowell E, Chou JF, Gewirtz AN, Borsu L, Vakiani E, Solit DB, Rosen N, Capanu M, Ladanyi M, Kemeny N (2014) RAS mutations affect pattern of metastatic spread and increase propensity for brain metastasis in colorectal cancer. Cancer. doi:10.1002/cncr.29196

    Google Scholar 

  26. Cejas P, Lopez-Gomez M, Aguayo C, Madero R, de Castro Carpeno J, Belda-Iniesta C, Barriuso J, Moreno Garcia V, Larrauri J, Lopez R, Casado E, Gonzalez-Baron M, Feliu J (2009) KRAS mutations in primary colorectal cancer tumors and related metastases: a potential role in prediction of lung metastasis. PLoS ONE 4(12):e8199. doi:10.1371/journal.pone.0008199

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  27. Zabaleta J, Aguinagalde B, Izquierdo JM, Bazterargui N, Laguna SM, Martin-Arruti M, Lobo C, Emparanza JI (2014) The presence of mutations in the K-RAS gene does not affect survival after resection of pulmonary metastases from colorectal cancer. ISRN Surg 2014:157586. doi:10.1155/2014/157586

    Article  PubMed  PubMed Central  Google Scholar 

  28. Vauthey JN, Zimmitti G, Kopetz SE, Shindoh J, Chen SS, Andreou A, Curley SA, Aloia TA, Maru DM (2013) RAS mutation status predicts survival and patterns of recurrence in patients undergoing hepatectomy for colorectal liver metastases. Annals of surgery 258(4):619–626. doi:10.1097/SLA.0b013e3182a5025a (discussion 626–617)

    Article  PubMed  Google Scholar 

  29. Pereira AA, Rego JF, Morris V, Overman MJ, Eng C, Garrett CR, Boutin AT, Ferrarotto R, Lee M, Jiang ZQ, Hoff PM, Vauthey JN, Vilar E, Maru D, Kopetz S (2015) Association between KRAS mutation and lung metastasis in advanced colorectal cancer. Br J Cancer 112(3):424–428. doi:10.1038/bjc.2014.619

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Urosevic J, Garcia-Albeniz X, Planet E, Real S, Cespedes MV, Guiu M, Fernandez E, Bellmunt A, Gawrzak S, Pavlovic M, Mangues R, Dolado I, Barriga FM, Nadal C, Kemeny N, Batlle E, Nebreda AR, Gomis RR (2014) Colon cancer cells colonize the lung from established liver metastases through p38 MAPK signalling and PTHLH. Nat Cell Biol 16(7):685–694. doi:10.1038/ncb2977

    Article  CAS  PubMed  Google Scholar 

  31. Yamauchi M, Morikawa T, Kuchiba A, Imamura Y, Qian ZR, Nishihara R, Liao X, Waldron L, Hoshida Y, Huttenhower C, Chan AT, Giovannucci E, Fuchs C, Ogino S (2012) Assessment of colorectal cancer molecular features along bowel subsites challenges the conception of distinct dichotomy of proximal versus distal colorectum. Gut 61(6):847–854. doi:10.1136/gutjnl-2011-300865

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Kaneko Y, Kuramochi H, Nakajima G, Inoue Y, Yamamoto M (2014) Degraded DNA may induce discordance of KRAS status between primary colorectal cancer and corresponding liver metastases. Int J Clin Oncol 19(1):113–120. doi:10.1007/s10147-012-0507-4

    Article  CAS  PubMed  Google Scholar 

  33. Baas JM, Krens LL, Guchelaar HJ, Morreau H, Gelderblom H (2011) Concordance of predictive markers for EGFR inhibitors in primary tumors and metastases in colorectal cancer: a review. Oncologist 16(9):1239–1249. doi:10.1634/theoncologist.2011-0024

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Douillard JY, Oliner KS, Siena S, Tabernero J, Burkes R, Barugel M, Humblet Y, Bodoky G, Cunningham D, Jassem J, Rivera F, Kocakova I, Ruff P, Blasinska-Morawiec M, Smakal M, Canon JL, Rother M, Williams R, Rong A, Wiezorek J, Sidhu R, Patterson SD (2013) Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer. New Engl J Med 369(11):1023–1034. doi:10.1056/NEJMoa1305275

    Article  CAS  PubMed  Google Scholar 

  35. Yap TA, Gerlinger M, Futreal PA, Pusztai L, Swanton C (2012) Intratumor heterogeneity: seeing the wood for the trees. Sci Transl Med 4(127):127ps110. doi:10.1126/scitranslmed.3003854

  36. Knijn N, Mekenkamp LJ, Klomp M, Vink-Borger ME, Tol J, Teerenstra S, Meijer JW, Tebar M, Riemersma S, van Krieken JH, Punt CJ, Nagtegaal ID (2011) KRAS mutation analysis: a comparison between primary tumours and matched liver metastases in 305 colorectal cancer patients. Br J Cancer 104(6):1020–1026. doi:10.1038/bjc.2011.26

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Baldus SE, Schaefer KL, Engers R, Hartleb D, Stoecklein NH, Gabbert HE (2010) Prevalence and heterogeneity of KRAS, BRAF, and PIK3CA mutations in primary colorectal adenocarcinomas and their corresponding metastases. Clin Cancer Res 16(3):790–799. doi:10.1158/1078-0432.CCR-09-2446

    Article  CAS  PubMed  Google Scholar 

  38. Santini D, Loupakis F, Vincenzi B, Floriani I, Stasi I, Canestrari E, Rulli E, Maltese PE, Andreoni F, Masi G, Graziano F, Baldi GG, Salvatore L, Russo A, Perrone G, Tommasino MR, Magnani M, Falcone A, Tonini G, Ruzzo A (2008) High concordance of KRAS status between primary colorectal tumors and related metastatic sites: implications for clinical practice. Oncologist 13(12):1270–1275. doi:10.1634/theoncologist.2008-0181

    Article  CAS  PubMed  Google Scholar 

  39. Artale S, Sartore-Bianchi A, Veronese SM, Gambi V, Sarnataro CS, Gambacorta M, Lauricella C, Siena S (2008) Mutations of KRAS and BRAF in primary and matched metastatic sites of colorectal cancer. J Clin Oncol 26(25):4217–4219. doi:10.1200/JCO.2008.18.7286

    Article  PubMed  Google Scholar 

  40. Etienne-Grimaldi MC, Formento JL, Francoual M, Francois E, Formento P, Renee N, Laurent-Puig P, Chazal M, Benchimol D, Delpero JR, Letoublon C, Pezet D, Seitz JF, Milano G (2008) K-Ras mutations and treatment outcome in colorectal cancer patients receiving exclusive fluoropyrimidine therapy. Clin Cancer Res 14(15):4830–4835. doi:10.1158/1078-0432.CCR-07-4906

    Article  CAS  PubMed  Google Scholar 

  41. Santini D, Spoto C, Loupakis F, Vincenzi B, Silvestris N, Cremolini C, Canestrari E, Graziano F, Galluccio N, Salvatore L, Caraglia M, Zito FA, Colucci G, Falcone A, Tonini G, Ruzzo A (2010) High concordance of BRAF status between primary colorectal tumours and related metastatic sites: implications for clinical practice. Ann Oncol 21(7):1565. doi:10.1093/annonc/mdq318

    Article  CAS  PubMed  Google Scholar 

  42. Vermaat JS, Nijman IJ, Koudijs MJ, Gerritse FL, Scherer SJ, Mokry M, Roessingh WM, Lansu N, de Bruijn E, van Hillegersberg R, van Diest PJ, Cuppen E, Voest EE (2012) Primary colorectal cancers and their subsequent hepatic metastases are genetically different: implications for selection of patients for targeted treatment. Clin Cancer Res 18(3):688–699. doi:10.1158/1078-0432.CCR-11-1965

    Article  CAS  PubMed  Google Scholar 

  43. Danner BC, Gerdes JS, Jung K, Sander B, Enders C, Liersch T, Seipelt R, Gutenberg A, Gunawan B, Schondube FA, Fuzesi L (2011) Comparison of chromosomal aberrations in primary colorectal carcinomas to their pulmonary metastases. Cancer Genet 204(3):122–128. doi:10.1016/j.cancergen.2010.12.003

    Article  CAS  PubMed  Google Scholar 

  44. Kahlert C, Pecqueux M, Halama N, Dienemann H, Muley T, Pfannschmidt J, Lasitschka F, Klupp F, Schmidt T, Rahbari N, Reissfelder C, Kunz C, Benner A, Falk C, Weitz J, Koch M (2014) Tumour-site-dependent expression profile of angiogenic factors in tumour-associated stroma of primary colorectal cancer and metastases. Br J Cancer 110(2):441–449. doi:10.1038/bjc.2013.745

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Pastorino U, Buyse M, Friedel G, Ginsberg RJ, Girard P, Goldstraw P, Johnston M, McCormack P, Pass H, Putnam Jr. JB, International Registry of Lung M (1997) Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases. J Thorac Cardiovasc Surg 113(1):37–49

    Article  CAS  PubMed  Google Scholar 

  46. Tampellini M, Ottone A, Bellini E, Alabiso I, Baratelli C, Bitossi R, Brizzi MP, Ferrero A, Sperti E, Leone F, Miraglia S, Forti L, Bertona E, Ardissone F, Berruti A, Alabiso O, Aglietta M, Scagliotti GV (2012) The role of lung metastasis resection in improving outcome of colorectal cancer patients: results from a large retrospective study. Oncologist 17(11):1430–1438. doi:10.1634/theoncologist.2012-0142

    Article  PubMed  PubMed Central  Google Scholar 

  47. Pfannschmidt J, Dienemann H, Hoffmann H (2007) Surgical resection of pulmonary metastases from colorectal cancer: a systematic review of published series. Ann Thorac Surg 84(1):324–338. doi:10.1016/j.athoracsur.2007.02.093

    Article  PubMed  Google Scholar 

  48. Jegatheeswaran S, Satyadas T, Sheen AJ, Treasure T, Siriwardena AK (2013) Thoracic surgical management of colorectal lung metastases: a questionnaire survey of members of the Society for Cardiothoracic Surgery in Great Britain and Ireland. Ann R Coll Surg Engl 95(2):140–143. doi:10.1308/003588413X13511609956336

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Treasure T, Fallowfield L, Lees B, Farewell V (2012) Pulmonary metastasectomy in colorectal cancer: the PulMiCC trial. Thorax 67(2):185–187. doi:10.1136/thoraxjnl-2011-200015

    Article  PubMed  Google Scholar 

  50. Kruger M, Schmitto JD, Wiegmann B, Rajab TK, Haverich A (2014) Optimal timing of pulmonary metastasectomy–is a delayed operation beneficial or counterproductive? Eur J Surg Oncol 40(9):1049–1055. doi:10.1016/j.ejso.2014.03.017

    Article  CAS  PubMed  Google Scholar 

  51. Wiegmann B, Internullo E, Cassivi SD, Van Raemdonck D, Friedel G, Treasure T, Group EPMW (2008) Pulmonary metastasectomy: a survey of current practice amongst members of the European Society of Thoracic Surgeons. J Thorac Oncol 3(11):1257–1266. doi:10.1097/JTO.0b013e31818bd9da

    Article  Google Scholar 

  52. Villeneuve PJ, Sundaresan RS (2009) Surgical management of colorectal lung metastasis. Clin Colon Rectal Surg 22(4):233–241. doi:10.1055/s-0029-1242463

    Article  PubMed  PubMed Central  Google Scholar 

  53. Kaifi JT, Gusani NJ, Deshaies I, Kimchi ET, Reed MF, Mahraj RP, Staveley-O’Carroll KF (2010) Indications and approach to surgical resection of lung metastases. J Surg Oncol 102(2):187–195. doi:10.1002/jso.21596

    Article  PubMed  Google Scholar 

  54. Hawkes EA, Ladas G, Cunningham D, Nicholson AG, Wassilew K, Barbachano Y, Ratnayake G, Rao S, Chau I (2012) Peri-operative chemotherapy in the management of resectable colorectal cancer pulmonary metastases. BMC Cancer 12:326. doi:10.1186/1471-2407-12-326

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  55. Perentes JY, Krueger T, Lovis A, Ris HB, Gonzalez M (2015) Thoracoscopic resection of pulmonary metastasis: current practice and results. Crit Rev Oncol 95(1):105–113. doi:10.1016/j.critrevonc.2015.02.005

    Article  Google Scholar 

  56. Limmer S, Unger L (2011) Optimal management of pulmonary metastases from colorectal cancer. Expert Rev Anticancer Ther 11(10):1567–1575. doi:10.1586/era.11.123

    Article  PubMed  Google Scholar 

  57. Berry MF (2014) Role of segmentectomy for pulmonary metastases. Ann Cardiothorac Surg 3(2):176–182. doi:10.3978/j.issn.2225-319X.2014.02.08

    PubMed  PubMed Central  Google Scholar 

  58. Greenwood A, West D (2013) Is a thoracotomy rather than thoracoscopic resection associated with improved survival after pulmonary metastasectomy? Interact CardioVasc Thorac Surg 17(4):720–724. doi:10.1093/icvts/ivt300

    Article  PubMed  PubMed Central  Google Scholar 

  59. Rolle A, Pereszlenyi A, Koch R, Richard M, Baier B (2006) Is surgery for multiple lung metastases reasonable? A total of 328 consecutive patients with multiple-laser metastasectomies with a new 1318-nm Nd:YAG laser. J Thorac Cardiovasc Surg 131(6):1236–1242. doi:10.1016/j.jtcvs.2005.11.053

    Article  PubMed  Google Scholar 

  60. Welter S, Jacobs J, Krbek T, Poettgen C, Stamatis G (2007) Prognostic impact of lymph node involvement in pulmonary metastases from colorectal cancer. Eur J Cardio-thoracic Surg 31(2):167–172. doi:10.1016/j.ejcts.2006.11.004

    Article  Google Scholar 

  61. Szoke T, Kortner A, Neu R, Grosser C, Sziklavari Z, Wiebe K, Hofmann HS (2010) Is the mediastinal lymphadenectomy during pulmonary metastasectomy of colorectal cancer necessary? Interact CardioVasc Thorac Surg 10(5):694–698. doi:10.1510/icvts.2009.213173

    Article  PubMed  Google Scholar 

  62. Loehe F, Kobinger S, Hatz RA, Helmberger T, Loehrs U, Fuerst H (2001) Value of systematic mediastinal lymph node dissection during pulmonary metastasectomy. Ann Thorac Surg 72(1):225–229

    Article  CAS  PubMed  Google Scholar 

  63. Dave RV, Pathak S, White AD, Hidalgo E, Prasad KR, Lodge JP, Milton R, Toogood GJ (2015) Outcome after liver resection in patients presenting with simultaneous hepatopulmonary colorectal metastases. Br J Surg 102(3):261–268. doi:10.1002/bjs.9737

    Article  CAS  PubMed  Google Scholar 

  64. Limmer S, Oevermann E, Killaitis C, Kujath P, Hoffmann M, Bruch HP (2010) Sequential surgical resection of hepatic and pulmonary metastases from colorectal cancer. Langenbeck’s Arch Surg 395(8):1129–1138. doi:10.1007/s00423-010-0595-4

    Article  Google Scholar 

  65. Andres A, Mentha G, Adam R, Gerstel E, Skipenko OG, Barroso E, Lopez-Ben S, Hubert C, Majno PE, Toso C (2015) Surgical management of patients with colorectal cancer and simultaneous liver and lung metastases. Br J Surg 102(6):691–699. doi:10.1002/bjs.9783

    Article  CAS  PubMed  Google Scholar 

  66. Schule S, Dittmar Y, Knosel T, Krieg P, Albrecht R, Settmacher U, Altendorf-Hofmann A (2012) Long-term results and prognostic factors after resection of hepatic and pulmonary metastases of colorectal cancer. Int J Colorectal Dis. doi:10.1007/s00384-012-1553-0

    PubMed  Google Scholar 

  67. Sakamoto Y, Sakaguchi Y, Oki E, Minami K, Toh Y, Okamura T (2012) Surgical outcomes after resection of both hepatic and pulmonary metastases from colorectal cancer. World J Surg 36(11):2708–2713. doi:10.1007/s00268-012-1708-8

    Article  PubMed  Google Scholar 

  68. Mineo TC, Ambrogi V, Tonini G, Bollero P, Roselli M, Mineo D, Nofroni I (2003) Longterm results after resection of simultaneous and sequential lung and liver metastases from colorectal carcinoma. J Am Coll Surg 197(3):386–391. doi:10.1016/S1072-7515(03)00387-9

    Article  PubMed  Google Scholar 

  69. Salah S, Ardissone F, Gonzalez M, Gervaz P, Riquet M, Watanabe K, Zabaleta J, Al-Rimawi D, Toubasi S, Massad E, Lisi E, Hamed OH (2015) Pulmonary metastasectomy in colorectal cancer patients with previously resected liver metastasis: pooled analysis. Ann Surg Oncol 22(6):1844–1850. doi:10.1245/s10434-014-4173-9

    Article  PubMed  Google Scholar 

  70. Hattori N, Kanemitsu Y, Komori K, Shimizu Y, Sano T, Senda Y, Mitsudomi T, Fukui T (2013) Outcomes after hepatic and pulmonary metastasectomies compared with pulmonary metastasectomy alone in patients with colorectal cancer metastasis to liver and lungs. World J Surg 37(6):1315–1321. doi:10.1007/s00268-013-1954-4

    Article  PubMed  Google Scholar 

  71. Inoue M, Ohta M, Iuchi K, Matsumura A, Ideguchi K, Yasumitsu T, Nakagawa K, Fukuhara K, Maeda H, Takeda S, Minami M, Ohno Y, Matsuda H, Thoracic Surgery Study Group of Osaka U (2004) Benefits of surgery for patients with pulmonary metastases from colorectal carcinoma. Ann Thorac Surg 78(1):238–244. doi:10.1016/j.athoracsur.2004.02.017

    Article  PubMed  Google Scholar 

  72. Mori M, Tomoda H, Ishida T, Kido A, Shimono R, Matsushima T, Kuwano H, Sugimachi K (1991) Surgical resection of pulmonary metastases from colorectal adenocarcinoma. Special reference to repeated pulmonary resections. Arch Surg 126(10):1297–1301 (discussion 1302)

    Article  CAS  PubMed  Google Scholar 

  73. Welter S, Jacobs J, Krbek T, Krebs B, Stamatis G (2007) Long-term survival after repeated resection of pulmonary metastases from colorectal cancer. Ann Thorac Surg 84(1):203–210. doi:10.1016/j.athoracsur.2007.03.028

    Article  PubMed  Google Scholar 

  74. Salah S, Watanabe K, Park JS, Addasi A, Park JW, Zabaleta J, Ardissone F, Kim J, Riquet M, Nojiri K, Gisabella M, Kim SY, Tanaka K (2013) Repeated resection of colorectal cancer pulmonary oligometastases: pooled analysis and prognostic assessment. Ann Surg Oncol 20(6):1955–1961. doi:10.1245/s10434-012-2860-y

    Article  PubMed  Google Scholar 

  75. Kandioler D, Kromer E, Tuchler H, End A, Muller MR, Wolner E, Eckersberger F (1998) Long-term results after repeated surgical removal of pulmonary metastases. Ann Thorac Surg 65(4):909–912

    Article  CAS  PubMed  Google Scholar 

  76. Saito Y, Omiya H, Kohno K, Kobayashi T, Itoi K, Teramachi M, Sasaki M, Suzuki H, Takao H, Nakade M (2002) Pulmonary metastasectomy for 165 patients with colorectal carcinoma: a prognostic assessment. J Thorac Cardiovasc Surg 124(5):1007–1013

    Article  PubMed  Google Scholar 

  77. Petre EN, Jia X, Thornton RH, Sofocleous CT, Alago W, Kemeny NE, Solomon SB (2013) Treatment of pulmonary colorectal metastases by radiofrequency ablation. Clin Colorectal Cancer 12(1):37–44. doi:10.1016/j.clcc.2012.07.003

    Article  PubMed  Google Scholar 

  78. Yamakado K, Inoue Y, Takao M, Takaki H, Nakatsuka A, Uraki J, Kashima M, Kusunoki M, Shimpo H, Takeda K (2009) Long-term results of radiofrequency ablation in colorectal lung metastases: single center experience. Oncol Rep 22(4):885–891

    Article  PubMed  Google Scholar 

  79. Yan TD, King J, Sjarif A, Glenn D, Steinke K, Al-Kindy A, Morris DL (2007) Treatment failure after percutaneous radiofrequency ablation for nonsurgical candidates with pulmonary metastases from colorectal carcinoma. Ann Surg Oncol 14(5):1718–1726. doi:10.1245/s10434-006-9271-x

    Article  PubMed  Google Scholar 

  80. Hiraki T, Gobara H, Iguchi T, Fujiwara H, Matsui Y, Kanazawa S (2014) Radiofrequency ablation as treatment for pulmonary metastasis of colorectal cancer. World J Gastroenterol 20(4):988–996. doi:10.3748/wjg.v20.i4.988

    Article  PubMed  PubMed Central  Google Scholar 

  81. de Baere T, Auperin A, Deschamps F, Chevallier P, Gaubert Y, Boige V, Fonck M, Escudier B, Palussiere J (2015) Radiofrequency ablation is a valid treatment option for lung metastases: experience in 566 patients with 1037 metastases. Ann Oncol 26(5):987–991. doi:10.1093/annonc/mdv037

    Article  PubMed  PubMed Central  Google Scholar 

  82. Steinke K, Sewell PE, Dupuy D, Lencioni R, Helmberger T, Kee ST, Jacob AL, Glenn DW, King J, Morris DL (2004) Pulmonary radiofrequency ablation: an international study survey. Anticancer Res 24(1):339–343

    PubMed  Google Scholar 

  83. Schlijper RC, Grutters JP, Houben R, Dingemans AM, Wildberger JE, Raemdonck DV, Cutsem EV, Haustermans K, Lammering G, Lambin P, Ruysscher DD (2013) What to choose as radical local treatment for lung metastases from colo-rectal cancer: Surgery or radiofrequency ablation? Cancer Treat Rev. doi:10.1016/j.ctrv.2013.05.004

    PubMed  Google Scholar 

  84. Comito T, Cozzi L, Clerici E, Campisi MC, Liardo RL, Navarria P, Ascolese A, Tozzi A, Iftode C, De Rose F, Villa E, Personeni N, Rimassa L, Santoro A, Fogliata A, Mancosu P, Tomatis S, Scorsetti M (2014) Stereotactic Ablative Radiotherapy (SABR) in inoperable oligometastatic disease from colorectal cancer: a safe and effective approach. BMC Cancer 14:619. doi:10.1186/1471-2407-14-619

    Article  PubMed  PubMed Central  Google Scholar 

  85. Filippi AR, Badellino S, Ceccarelli M, Guarneri A, Franco P, Monagheddu C, Spadi R, Ragona R, Racca P, Ricardi U (2014) Stereotactic ablative radiation therapy as first local therapy for lung oligometastases from colorectal cancer: a single-institution cohort study. Int J Radiat Oncol Biol Phys. doi:10.1016/j.ijrobp.2014.10.046

    Google Scholar 

  86. Thibault I, Poon I, Yeung L, Erler D, Kim A, Keller B, Lochray F, Jain S, Soliman H, Cheung P (2014) Predictive factors for local control in primary and metastatic lung tumours after four to five fraction stereotactic ablative body radiotherapy: a single institution’s comprehensive experience. Clin Oncol 26(11):713–719. doi:10.1016/j.clon.2014.06.018

    Article  CAS  Google Scholar 

  87. Bar J, Herbst RS, Onn A (2009) Targeted drug delivery strategies to treat lung metastasis. Expert Opin Drug Deliv 6(10):1003–1016. doi:10.1517/17425240903167926

    Article  CAS  PubMed  Google Scholar 

  88. Yamauchi Y, Izumi Y, Kawamura M, Nakatsuka S, Yashiro H, Tsukada N, Inoue M, Asakura K, Nomori H (2011) Percutaneous cryoablation of pulmonary metastases from colorectal cancer. PLoS ONE 6(11):e27086. doi:10.1371/journal.pone.0027086

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  89. Shi S, Yang J, Sun D (2015) CT-guided I brachytherapy on pulmonary metastases after resection of colorectal cancer: a report of six cases. Oncol Lett 9(1):375–380. doi:10.3892/ol.2014.2649

    PubMed  PubMed Central  Google Scholar 

  90. Nordlinger B, Sorbye H, Glimelius B, Poston GJ, Schlag PM, Rougier P, Bechstein WO, Primrose JN, Walpole ET, Finch-Jones M, Jaeck D, Mirza D, Parks RW, Collette L, Praet M, Bethe U, Van Cutsem E, Scheithauer W, Gruenberger T, Group EG-ITC, Cancer Research UK, Arbeitsgruppe Lebermetastasen und-tumoren in der Chirurgischen Arbeitsgemeinschaft O, Australasian Gastro-Intestinal Trials G, Federation Francophone de Cancerologie D (2008) Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet 371(9617):1007–1016. doi:10.1016/S0140-6736(08)60455-9

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  91. Nordlinger B, Sorbye H, Glimelius B, Poston GJ, Schlag PM, Rougier P, Bechstein WO, Primrose JN, Walpole ET, Finch-Jones M, Jaeck D, Mirza D, Parks RW, Collette L, Praet M, Bethe U, Van Cutsem E, Scheithauer W, Gruenberger T, Group EG-ITC, Cancer Research UK, Arbeitsgruppe Lebermetastasen und-tumoren in der Chirurgischen Arbeitsgemeinschaft O, Australasian Gastro-Intestinal Trials G, Federation Francophone de Cancerologie D (2013) Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial. Lancet Oncol 14(12):1208–1215. doi:10.1016/S1470-2045(13)70447-9

    Article  CAS  PubMed  Google Scholar 

  92. Li WH, Peng JJ, Xiang JQ, Chen W, Cai SJ, Zhang W (2010) Oncological outcome of unresectable lung metastases without extrapulmonary metastases in colorectal cancer. World J Gastroenterol 16(26):3318–3324

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  93. Younes RN, Abrao F, Gross J (2013) Pulmonary metastasectomy for colorectal cancer: long-term survival and prognostic factors. Int J Surg 11(3):244–248. doi:10.1016/j.ijsu.2013.01.003

    Article  CAS  PubMed  Google Scholar 

  94. Lee WS, Yun SH, Chun HK, Lee WY, Yun HR, Kim J, Kim K, Shim YM (2007) Pulmonary resection for metastases from colorectal cancer: prognostic factors and survival. Int J Colorectal Dis 22(6):699–704. doi:10.1007/s00384-006-0218-2

    Article  PubMed  Google Scholar 

  95. Maeda R, Isowa N, Onuma H, Miura H, Harada T, Touge H, Tokuyasu H, Kawasaki Y (2009) Pulmonary resection for metastases from colorectal carcinoma. Interact CardioVasc Thorac Surg 9(4):640–644. doi:10.1510/icvts.2009.202598

    Article  PubMed  Google Scholar 

  96. Kanemitsu Y, Kato T, Hirai T, Yasui K (2004) Preoperative probability model for predicting overall survival after resection of pulmonary metastases from colorectal cancer. Br J Surg 91(1):112–120. doi:10.1002/bjs.4370

    Article  CAS  PubMed  Google Scholar 

  97. Mitry E, Fields AL, Bleiberg H, Labianca R, Portier G, Tu D, Nitti D, Torri V, Elias D, O’Callaghan C, Langer B, Martignoni G, Bouche O, Lazorthes F, Van Cutsem E, Bedenne L, Moore MJ, Rougier P (2008) Adjuvant chemotherapy after potentially curative resection of metastases from colorectal cancer: a pooled analysis of two randomized trials. J Clin Oncol 26(30):4906–4911. doi:10.1200/JCO.2008.17.3781

    Article  CAS  PubMed  Google Scholar 

  98. Koga R, Yamamoto J, Saiura A, Yamaguchi T, Hata E, Sakamoto M (2006) Surgical resection of pulmonary metastases from colorectal cancer: four favourable prognostic factors. Jpn J Clin Oncol 36(10):643–648. doi:10.1093/jjco/hyl076

    Article  PubMed  Google Scholar 

  99. Girard P, Ducreux M, Baldeyrou P, Rougier P, Le Chevalier T, Bougaran J, Lasser P, Gayet B, Ruffie P, Grunenwald D (1996) Surgery for lung metastases from colorectal cancer: analysis of prognostic factors. J Clin Oncol 14(7):2047–2053

    CAS  PubMed  Google Scholar 

  100. Zampino MG, Maisonneuve P, Ravenda PS, Magni E, Casiraghi M, Solli P, Petrella F, Gasparri R, Galetta D, Borri A, Donghi S, Veronesi G, Spaggiari L (2014) Lung metastases from colorectal cancer: analysis of prognostic factors in a single institution study. Ann Thorac Surg 98(4):1238–1245. doi:10.1016/j.athoracsur.2014.05.048

    Article  PubMed  Google Scholar 

  101. Renaud S, Falcoz PE, Olland A, Schaeffer M, Reeb J, Santelmo N, Massard G (2015) The intrathoracic lymph node ratio seems to be a better prognostic factor than the level of lymph node involvement in lung metastasectomy of colorectal carcinoma. Interact CardioVasc Thorac Surg 20(2):215–221. doi:10.1093/icvts/ivu364

    Article  PubMed  Google Scholar 

  102. Pfannschmidt J, Bade S, Hoheisel J, Muley T, Dienemann H, Herpel E (2009) Identification of immunohistochemical prognostic markers for survival after resection of pulmonary metastases from colorectal carcinoma. Thorac Cardiovasc Surg 57(7):403–408. doi:10.1055/s-0029-1185820

    Article  CAS  PubMed  Google Scholar 

  103. Gonzalez M, Poncet A, Combescure C, Robert J, Ris HB, Gervaz P (2013) Risk factors for survival after lung metastasectomy in colorectal cancer patients: a systematic review and meta-analysis. Ann Surg Oncol 20(2):572–579. doi:10.1245/s10434-012-2726-3

    Article  PubMed  Google Scholar 

  104. Tamura M, Oda M, Tsunezuka Y, Matsumoto I, Kawakami K, Watanabe G (2004) Vascular endothelial growth factor expression in metastatic pulmonary tumor from colorectal carcinoma: utility as a prognostic factor. J Thorac Cardiovasc Surg 128(4):517–522. doi:10.1016/j.jtcvs.2004.03.056

    Article  CAS  PubMed  Google Scholar 

  105. Cho S, Song IH, Yang HC, Jheon S (2013) Prognostic factors of pulmonary metastasis from colorectal carcinoma. Interact CardioVasc Thorac Surg 17(2):303–307. doi:10.1093/icvts/ivt164

    Article  PubMed  PubMed Central  Google Scholar 

  106. Goonerante D, Gray C, Lim M, Dixon L, Dobbs B, Wakeman C, Frizelle F, Colorectal Lung Metastases Research (2012) Survival outcome in New Zealand after resection of colorectal cancer lung metastases. ANZ J Surg. doi:10.1111/ans.12012

    PubMed  Google Scholar 

  107. Embun R, Fiorentino F, Treasure T, Rivas JJ, Molins L, Grupo Espanol de Cirugia Metastasis Pulmonares de Carcinoma Colo-Rectal de la Sociedad Espanola de Neumolona y Cirurna T (2013) Pulmonary metastasectomy in colorectal cancer: a prospective study of demography and clinical characteristics of 543 patients in the Spanish colorectal metastasectomy registry (GECMP-CCR). BMJ Open 3(5):e008711. doi:10.1136/bmjopen-2013-002787

    Article  Google Scholar 

  108. Landes U, Robert J, Perneger T, Mentha G, Ott V, Morel P, Gervaz P (2010) Predicting survival after pulmonary metastasectomy for colorectal cancer: previous liver metastases matter. BMC Surg 10:17. doi:10.1186/1471-2482-10-17

    Article  PubMed  PubMed Central  Google Scholar 

  109. Cho JH, Hamaji M, Allen MS, Cassivi SD, Nichols FC 3rd, Wigle DA, Shen KR, Deschamps C (2014) The prognosis of pulmonary metastasectomy depends on the location of the primary colorectal cancer. Ann Thorac Surg 98(4):1231–1237. doi:10.1016/j.athoracsur.2014.05.023

    Article  PubMed  Google Scholar 

  110. Chen F, Hanaoka N, Sato K, Fujinaga T, Sonobe M, Shoji T, Sakai H, Miyahara R, Bando T, Okubo K, Hirata T, Date H (2009) Prognostic factors of pulmonary metastasectomy for colorectal carcinomas. World J Surg 33(3):505–511. doi:10.1007/s00268-008-9875-3

    Article  CAS  PubMed  Google Scholar 

  111. Shiono S, Ishii G, Nagai K, Murata Y, Tsuta K, Nitadori J, Kodama T, Ochiai A (2006) Immunohistochemical prognostic factors in resected colorectal lung metastases using tissue microarray analysis. Eur J Surg Oncol 32(3):308–309. doi:10.1016/j.ejso.2005.12.003

    Article  CAS  PubMed  Google Scholar 

  112. Primrose JN, Perera R, Gray A, Rose P, Fuller A, Corkhill A, George S, Mant D, Investigators FT (2014) Effect of 3 to 5 years of scheduled CEA and CT follow-up to detect recurrence of colorectal cancer: the FACS randomized clinical trial. J Am Med Assoc 311(3):263–270. doi:10.1001/jama.2013.285718

    Article  CAS  Google Scholar 

  113. Cerfolio RJMT, Bryant AS (2009) Non-imaged pulmonary nodules discovered during thoracotomy for metastasectomy by lung palpation. Eur J Cardio-thoracic Surg 35(5):786–791 (discussion 791)

    Article  Google Scholar 

  114. Pastorino U, Veronesi G, Landoni C, Leon M, Picchio M, Solli PG, Leo F, Spaggiari L, Pelosi G, Bellomi M, Fazio F (2003) Fluorodeoxyglucose positron emission tomography improves preoperative staging of resectable lung metastasis. J Thorac Cardiovasc Surg 126(6):1906–1910. doi:10.1016/S0022

    Article  CAS  PubMed  Google Scholar 

  115. Detterbeck FC, Grodzki T, Gleeson F, Robert JH (2010) Imaging requirements in the practice of pulmonary metastasectomy. J Thorac Oncol 5(6 Suppl 2):S134–S139. doi:10.1097/JTO.0b013e3181dcf64d

    Article  PubMed  Google Scholar 

  116. Limmer S, Dicken V, Kujath P, Krass S, Stocker C, Wendt N, Unger L, Hoffmann M, Vogt F, Kleemann M, Bruch HP, Peitgen HO (2010) Three-dimensional reconstruction of central lung tumors based on CT data. Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen 81(9):833–840. doi:10.1007/s00104-009-1828-3

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We acknowledge support from the National Institute for Health Research Royal Marsden/Institute of Cancer Research (NIHR RM/ICR) Biomedical Research Centre.

Author information

Authors and Affiliations

  1. Gastrointestinal Unit, Department of Medicine, The Royal Marsden NHS Foundation Trust, Surrey, UK

    Sing Yu Moorcraft & Ian Chau

  2. Department of Thoracic Surgery, Royal Brompton and Harefield NHS Foundation Trust, London, UK

    George Ladas

  3. National Heart and Lung Institute, Imperial College, London, UK

    Anne Bowcock

Authors
  1. Sing Yu Moorcraft
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. George Ladas
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Anne Bowcock
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ian Chau
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ian Chau.

Ethics declarations

Conflict of interest

None of the authors have any conflicts of interest to declare.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Moorcraft, S.Y., Ladas, G., Bowcock, A. et al. Management of resectable colorectal lung metastases. Clin Exp Metastasis 33, 285–296 (2016). https://doi.org/10.1007/s10585-015-9774-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10585-015-9774-6

Keywords

Search

Navigation